Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Return on Sales: 2015-2025

Historic Return on Sales for CytomX Therapeutics (CTMX) over the last 11 years, with Sep 2025 value amounting to 0.25%.

  • CytomX Therapeutics' Return on Sales rose 14.00% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 14.00%. This contributed to the annual value of 0.23% for FY2024, which is 24.00% up from last year.
  • CytomX Therapeutics' Return on Sales amounted to 0.25% in Q3 2025, which was down 27.49% from 0.34% recorded in Q2 2025.
  • Over the past 5 years, CytomX Therapeutics' Return on Sales peaked at 0.34% during Q2 2025, and registered a low of -3.28% during Q1 2021.
  • Its 3-year average for Return on Sales is -0.02%, with a median of 0.11% in 2024.
  • Per our database at Business Quant, CytomX Therapeutics' Return on Sales tumbled by 176bps in 2021 and then skyrocketed by 273bps in 2023.
  • Over the past 5 years, CytomX Therapeutics' Return on Sales (Quarterly) stood at -3.11% in 2021, then surged by 124bps to -1.87% in 2022, then soared by 186bps to -0.01% in 2023, then grew by 24bps to 0.23% in 2024, then rose by 14bps to 0.25% in 2025.
  • Its Return on Sales stands at 0.25% for Q3 2025, versus 0.34% for Q2 2025 and 0.28% for Q1 2025.